Cargando…
LIPI及iSEND免疫评分在晚期非小细胞肺癌免疫治疗中的预测价值分析
BACKGROUND AND OBJECTIVE: This study retrospectively analyzed the application value of lung cancer immunotherapy prognostic index (LIPI) and iSEND immune scoring system in advanced non-small cell lung cancer (NSCLC) patients treated with immunotherapy in China, in order to find guidance for clinical...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720679/ https://www.ncbi.nlm.nih.gov/pubmed/36419394 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.47 |